Proximity of TPR and NTRK1 rearranging loci in human thyrocytes

Emanuela Roccato1, Paola Bressan, Guido Sabatella

  • 1Department of Experimental Oncology Operative Unit Molecular Mechanisms of Cancer Growth and Progression, Istituto Nazionale Tumori, Milan, Italy.

Cancer Research
|April 5, 2005
PubMed

Insights

Thyroid cancer involves gene rearrangements. Researchers found that proximity of specific gene loci in thyroid cells, compared to blood cells, may increase the risk of these cancer-associated rearrangements.

Area of Science:

  • Genetics
  • Cancer Biology
  • Molecular Oncology

Background:

  • Chromosomal rearrangements are common in cancer, but their cell-type specificity is unclear.
  • Papillary thyroid carcinomas frequently exhibit rearrangements of RET and NTRK1 tyrosine kinase receptor genes, forming oncogenes.
  • Previous work suggests spatial proximity of RET and H4 loci in thyrocytes favors recombination.

Purpose of the Study:

  • To investigate if spatial proximity of the NTRK1 gene and its oncogenic partner TPR contributes to thyroid-specific TRK oncogene formation.
  • To compare the spatial arrangement of these loci in thyroid cells versus peripheral blood lymphocytes.

Main Methods:

  • Two-color fluorescence in situ hybridization (FISH) was used to determine the distance between NTRK1 and TPR loci.
  • Two-dimensional microscopy and three-dimensional reconstruction of FISH data were employed.
  • Spatial distances were analyzed in thyrocytes and peripheral blood lymphocytes.

Main Results:

  • The distance between the NTRK1 and TPR loci was significantly reduced in thyrocytes compared to peripheral blood lymphocytes.
  • This spatial proximity in thyrocytes supports a mechanism for enhanced gene rearrangement.

Conclusions:

  • Spatial proximity of translocation-prone gene loci, like NTRK1 and TPR, in thyrocytes may favor the generation of oncogenic rearrangements.
  • This finding contributes to understanding the cell-type specificity of chromosomal rearrangements in cancer.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the timing and level of...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...